LifeStance Health Group (LFST) Competitors

LifeStance Health Group logo
$14.17 -0.31 (-2.14%)
Closing price 11/17/2026 04:00 PM Eastern
Extended Trading
$14.20 +0.04 (+0.25%)
As of 06:51 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

LFST vs. GH, TEM, BTSG, FMS, and DVA

Should you buy LifeStance Health Group stock or one of its competitors? LifeStance Health Group's main competitors and comparable companies include Guardant Health (GH), Tempus AI (TEM), BrightSpring Health Services (BTSG), Fresenius Medical Care AG & Co. KGaA (FMS), and DaVita (DVA). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does LifeStance Health Group compare to Guardant Health?

Guardant Health (NASDAQ:GH) and LifeStance Health Group (NASDAQ:LFST) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, risk, dividends, earnings, media sentiment, analyst recommendations, institutional ownership and profitability.

92.6% of Guardant Health shares are held by institutional investors. Comparatively, 85.5% of LifeStance Health Group shares are held by institutional investors. 5.6% of Guardant Health shares are held by insiders. Comparatively, 3.5% of LifeStance Health Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Guardant Health has a beta of 1.67, suggesting that its stock price is 67% more volatile than the broader market. Comparatively, LifeStance Health Group has a beta of 1.35, suggesting that its stock price is 35% more volatile than the broader market.

LifeStance Health Group has a net margin of 4.29% compared to Guardant Health's net margin of -37.93%. LifeStance Health Group's return on equity of 4.82% beat Guardant Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Guardant Health-37.93% N/A -25.03%
LifeStance Health Group 4.29%4.82%3.30%

LifeStance Health Group has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Guardant Health$982.02M19.74-$416.28M-$3.68N/A
LifeStance Health Group$1.42B3.78$9.66M$0.1974.58

In the previous week, Guardant Health had 7 more articles in the media than LifeStance Health Group. MarketBeat recorded 17 mentions for Guardant Health and 10 mentions for LifeStance Health Group. LifeStance Health Group's average media sentiment score of 0.44 beat Guardant Health's score of 0.05 indicating that LifeStance Health Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Guardant Health
5 Very Positive mention(s)
0 Positive mention(s)
8 Neutral mention(s)
1 Negative mention(s)
1 Very Negative mention(s)
Neutral
LifeStance Health Group
5 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Guardant Health currently has a consensus target price of $190.88, suggesting a potential upside of 33.22%. LifeStance Health Group has a consensus target price of $14.86, suggesting a potential upside of 4.85%. Given Guardant Health's stronger consensus rating and higher possible upside, equities research analysts plainly believe Guardant Health is more favorable than LifeStance Health Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Guardant Health
1 Sell rating(s)
0 Hold rating(s)
24 Buy rating(s)
1 Strong Buy rating(s)
2.96
LifeStance Health Group
0 Sell rating(s)
4 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.70

Summary

Guardant Health and LifeStance Health Group tied by winning 8 of the 16 factors compared between the two stocks.

How does LifeStance Health Group compare to Tempus AI?

LifeStance Health Group (NASDAQ:LFST) and Tempus AI (NASDAQ:TEM) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, media sentiment, earnings, institutional ownership, dividends, profitability, risk and valuation.

LifeStance Health Group has higher revenue and earnings than Tempus AI. Tempus AI is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LifeStance Health Group$1.42B3.78$9.66M$0.1974.58
Tempus AI$1.27B9.10-$245.03M-$1.06N/A

LifeStance Health Group has a beta of 1.35, meaning that its share price is 35% more volatile than the broader market. Comparatively, Tempus AI has a beta of 3.61, meaning that its share price is 261% more volatile than the broader market.

LifeStance Health Group presently has a consensus price target of $14.86, indicating a potential upside of 4.85%. Tempus AI has a consensus price target of $79.37, indicating a potential upside of 25.13%. Given Tempus AI's higher possible upside, analysts clearly believe Tempus AI is more favorable than LifeStance Health Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LifeStance Health Group
0 Sell rating(s)
4 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.70
Tempus AI
1 Sell rating(s)
10 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.45

LifeStance Health Group has a net margin of 4.29% compared to Tempus AI's net margin of -12.54%. LifeStance Health Group's return on equity of 4.82% beat Tempus AI's return on equity.

Company Net Margins Return on Equity Return on Assets
LifeStance Health Group4.29% 4.82% 3.30%
Tempus AI -12.54%-47.00%-9.44%

85.5% of LifeStance Health Group shares are held by institutional investors. Comparatively, 24.2% of Tempus AI shares are held by institutional investors. 3.5% of LifeStance Health Group shares are held by insiders. Comparatively, 24.3% of Tempus AI shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, LifeStance Health Group and LifeStance Health Group both had 10 articles in the media. Tempus AI's average media sentiment score of 0.77 beat LifeStance Health Group's score of 0.44 indicating that Tempus AI is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
LifeStance Health Group
5 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Tempus AI
5 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Positive

Summary

LifeStance Health Group beats Tempus AI on 10 of the 16 factors compared between the two stocks.

How does LifeStance Health Group compare to BrightSpring Health Services?

BrightSpring Health Services (NASDAQ:BTSG) and LifeStance Health Group (NASDAQ:LFST) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, earnings, analyst recommendations, risk, valuation, dividends, media sentiment and institutional ownership.

BrightSpring Health Services presently has a consensus price target of $77.81, suggesting a potential upside of 11.43%. LifeStance Health Group has a consensus price target of $14.86, suggesting a potential upside of 4.85%. Given BrightSpring Health Services' stronger consensus rating and higher possible upside, research analysts plainly believe BrightSpring Health Services is more favorable than LifeStance Health Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BrightSpring Health Services
0 Sell rating(s)
0 Hold rating(s)
17 Buy rating(s)
2 Strong Buy rating(s)
3.11
LifeStance Health Group
0 Sell rating(s)
4 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.70

BrightSpring Health Services has higher revenue and earnings than LifeStance Health Group. BrightSpring Health Services is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BrightSpring Health Services$12.91B1.08$190.67M$1.8537.75
LifeStance Health Group$1.42B3.78$9.66M$0.1974.58

BrightSpring Health Services has a beta of 1.77, indicating that its stock price is 77% more volatile than the broader market. Comparatively, LifeStance Health Group has a beta of 1.35, indicating that its stock price is 35% more volatile than the broader market.

LifeStance Health Group has a net margin of 4.29% compared to BrightSpring Health Services' net margin of 2.69%. BrightSpring Health Services' return on equity of 18.56% beat LifeStance Health Group's return on equity.

Company Net Margins Return on Equity Return on Assets
BrightSpring Health Services2.69% 18.56% 6.03%
LifeStance Health Group 4.29%4.82%3.30%

In the previous week, LifeStance Health Group had 5 more articles in the media than BrightSpring Health Services. MarketBeat recorded 10 mentions for LifeStance Health Group and 5 mentions for BrightSpring Health Services. BrightSpring Health Services' average media sentiment score of 0.89 beat LifeStance Health Group's score of 0.44 indicating that BrightSpring Health Services is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
BrightSpring Health Services
3 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
LifeStance Health Group
5 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

85.5% of LifeStance Health Group shares are held by institutional investors. 2.8% of BrightSpring Health Services shares are held by company insiders. Comparatively, 3.5% of LifeStance Health Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

BrightSpring Health Services beats LifeStance Health Group on 11 of the 17 factors compared between the two stocks.

How does LifeStance Health Group compare to Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) and LifeStance Health Group (NASDAQ:LFST) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, media sentiment, valuation, profitability, analyst recommendations, earnings and dividends.

8.4% of Fresenius Medical Care AG & Co. KGaA shares are owned by institutional investors. Comparatively, 85.5% of LifeStance Health Group shares are owned by institutional investors. 3.5% of LifeStance Health Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than LifeStance Health Group. Fresenius Medical Care AG & Co. KGaA is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fresenius Medical Care AG & Co. KGaA$22.20B0.52$1.11B$1.7312.55
LifeStance Health Group$1.42B3.78$9.66M$0.1974.58

Fresenius Medical Care AG & Co. KGaA presently has a consensus price target of $23.43, suggesting a potential upside of 7.92%. LifeStance Health Group has a consensus price target of $14.86, suggesting a potential upside of 4.85%. Given Fresenius Medical Care AG & Co. KGaA's higher possible upside, equities analysts plainly believe Fresenius Medical Care AG & Co. KGaA is more favorable than LifeStance Health Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Fresenius Medical Care AG & Co. KGaA
5 Sell rating(s)
7 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.58
LifeStance Health Group
0 Sell rating(s)
4 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.70

LifeStance Health Group has a net margin of 4.29% compared to Fresenius Medical Care AG & Co. KGaA's net margin of 4.23%. Fresenius Medical Care AG & Co. KGaA's return on equity of 9.08% beat LifeStance Health Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Fresenius Medical Care AG & Co. KGaA4.23% 9.08% 4.04%
LifeStance Health Group 4.29%4.82%3.30%

In the previous week, LifeStance Health Group had 5 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 10 mentions for LifeStance Health Group and 5 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 1.38 beat LifeStance Health Group's score of 0.44 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Fresenius Medical Care AG & Co. KGaA
5 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
LifeStance Health Group
5 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Fresenius Medical Care AG & Co. KGaA has a beta of 0.78, suggesting that its share price is 22% less volatile than the broader market. Comparatively, LifeStance Health Group has a beta of 1.35, suggesting that its share price is 35% more volatile than the broader market.

Summary

LifeStance Health Group beats Fresenius Medical Care AG & Co. KGaA on 10 of the 17 factors compared between the two stocks.

How does LifeStance Health Group compare to DaVita?

LifeStance Health Group (NASDAQ:LFST) and DaVita (NYSE:DVA) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, earnings, media sentiment, analyst recommendations, dividends, valuation, profitability and institutional ownership.

LifeStance Health Group currently has a consensus price target of $14.86, suggesting a potential upside of 4.85%. DaVita has a consensus price target of $235.86, suggesting a potential upside of 36.22%. Given DaVita's higher probable upside, analysts plainly believe DaVita is more favorable than LifeStance Health Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LifeStance Health Group
0 Sell rating(s)
4 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.70
DaVita
0 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.57

LifeStance Health Group has a beta of 1.35, indicating that its share price is 35% more volatile than the broader market. Comparatively, DaVita has a beta of 0.87, indicating that its share price is 13% less volatile than the broader market.

DaVita has higher revenue and earnings than LifeStance Health Group. DaVita is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LifeStance Health Group$1.42B3.78$9.66M$0.1974.58
DaVita$13.64B0.80$746.80M$13.5812.75

DaVita has a net margin of 6.49% compared to LifeStance Health Group's net margin of 4.29%. LifeStance Health Group's return on equity of 4.82% beat DaVita's return on equity.

Company Net Margins Return on Equity Return on Assets
LifeStance Health Group4.29% 4.82% 3.30%
DaVita 6.49%-225.93%5.42%

In the previous week, LifeStance Health Group and LifeStance Health Group both had 10 articles in the media. DaVita's average media sentiment score of 0.49 beat LifeStance Health Group's score of 0.44 indicating that DaVita is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
LifeStance Health Group
5 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
DaVita
2 Very Positive mention(s)
2 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

85.5% of LifeStance Health Group shares are held by institutional investors. Comparatively, 90.1% of DaVita shares are held by institutional investors. 3.5% of LifeStance Health Group shares are held by company insiders. Comparatively, 1.9% of DaVita shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

LifeStance Health Group and DaVita tied by winning 8 of the 16 factors compared between the two stocks.

Get LifeStance Health Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for LFST and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LFST and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

LFST vs. The Competition

MetricLifeStance Health GroupHealthcare Providers & Services IndustryHealthcare SectorNASDAQ Exchange
Market Cap$5.51B$10.88B$7.83B$11.74B
Dividend YieldN/A2.54%2.47%4.47%
P/E Ratio74.5836.3134.2628.24
Price / Sales3.782.108.485.70
Price / Cash86.0822.8921.0121.90
Price / Book3.613.574.463.72
Net Income$9.66M$332.46M$3.52B$393.10M
7 Day Performance-1.39%-4.23%-5.92%-5.76%
1 Month Performance20.70%-1.71%-4.58%-7.14%
1 Year Performance128.55%19.26%-1.93%-7.46%

LifeStance Health Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
LFST
LifeStance Health Group
3.0722 of 5 stars
$14.17
-2.1%
$14.86
+4.8%
+126.7%$5.51B$1.42B74.5810,961
GH
Guardant Health
3.7982 of 5 stars
$155.35
-2.2%
$190.88
+22.9%
+48.5%$20.85B$982.02MN/A2,506
TEM
Tempus AI
3.4736 of 5 stars
$80.54
-4.6%
$79.37
-1.5%
-4.5%$14.53B$1.27BN/A3,800
BTSG
BrightSpring Health Services
3.6792 of 5 stars
$72.49
+4.8%
$77.81
+7.3%
+122.7%$14.42B$12.91B39.1823,500
FMS
Fresenius Medical Care AG & Co. KGaA
3.6608 of 5 stars
$22.75
-0.9%
$23.43
+3.0%
-5.7%$12.11B$22.20B13.151,488

Related Companies and Tools


This page (NASDAQ:LFST) was last updated on 11/18/2026 by MarketBeat.com Staff.
From Our Partners